CELEX: 32010M5990
Language: en
Date: 2010-11-10 00:00:00
Title: Commission Decision of 10/11/2010 declaring a concentration to be compatible with the common market (Case No COMP/M.5990 - INVESTOR / MOLNLYCKE) according to Council Regulation (EC) No 139/2004 (Only the English text is authentic)

|

32010M5990

Commission Decision of 10/11/2010 declaring a concentration to be compatible with the common market (Case No COMP/M.5990 - INVESTOR / MOLNLYCKE) according to Council Regulation (EC) No 139/2004 (Only the English text is authentic)  

         (.PICT.)(.PICT.) |EUROPEAN COMMISSION     |
            Brussels , 10.11.2010
             SG-Greffe(2010) D/17952
             C(2010) 7928
             PUBLIC VERSION
             MERGER PROCEDURE ARTICLE 6(1)(b) DECISION
             SIMPLIFIED PROCEDURE
              To the notifying party:
             Dear Madam(s) and/or Sir(s),
             Subject: Case No COMP/M.5990 - INVESTOR/ MOLNLYCKE Notification of 07.10.2010 pursuant to Article 4 of Council Regulation (EC) No 139/2004  [1]  Publication in the Official Journal of the European Union No C 277, 14.10.2010 p.19
            1.  On 07.10.2010, the European Commission received notification of a proposed concentration pursuant to Article 4 of the Merger Regulation by which Investor AB ("Investor", Sweden), controlled by the Knut and Alice Wallenberg Foundation, acquires within the meaning of Article 3(1)(b) of the Merger Regulation sole control of Mölnlycke AB ("Mölnlycke", Sweden, currently jointly controlled by Investor and Morgan Stanley) by purchase of shares.
            2.  The business activities of the undertakings concerned are:
             -  Investor: industrial holding company active in the following business areas: core investments (shareholdings in listed companies), operating investments (notably in Aleris, a private healthcare company and in Mölnlycke), private equity investments and financial investments;
             -  Mölnlycke: manufacturer and supplier of single-use surgical and wound care products, primarily for the professional healthcare sector.
            3.  After examination of the notification, the European Commission has concluded that the notified operation falls within the scope of the Merger Regulation and of paragraph 5(d) of the Commission Notice on a simplified procedure for treatment of certain concentrations under Council Regulation (EC) No 139/2004 [2]  .  
            4.  For the reasons set out in the Notice on a simplified procedure, the European Commission has decided not to oppose the notified operation and to declare it compatible with the internal market and with the EEA Agreement. This decision is adopted in application of Article 6(1)(b) of the Merger Regulation.
             For the European Commission, (signed) Alexander ITALIANER Director General
            [1]OJ L 24, 29.1.2004, p. 1 ("the Merger Regulation"). With effect from 1 December 2009, the Treaty on the Functioning of the European Union ("TFEU") has introduced certain changes, such as the replacement of "Community" by "Union" and "common market" by "internal market". The terminology of the TFEU will be used throughout this decision.
            [2] OJ C 56, 5.3.2005, p. 32.